SERVICE & PRODUCT
Cancer Drug Monitoring
>
SERVICE & PRODUCT
>
Cancer Drug Monitoring
- Liquid biopsies monitor the therapeutic response of the anticancer drug and predicts a relapse of cancer.
- Comparison of survival curves using Kaplan-Meier Survival Analysis in presence or absence of CTCs
Progression-free survival
Overall Survival
- Throughout cancer treatment, a CTC-based liquid biopsy is performed with periodically withdrawn blood from cancer patients.
- Analysis of CTCs uncovers the response and prognosis of a patient to the cancer treatment.